These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24679487)

  • 1. Living with addiction: the perspectives of drug using and non-using individuals about sharing space in a hospital setting.
    Strike C; Guta A; de Prinse K; Switzer S; Chan Carusone S
    Int J Drug Policy; 2014 May; 25(3):640-9. PubMed ID: 24679487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
    Gidman W; Coomber R
    Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualizing harm reduction: Methodological and ethical considerations.
    Switzer S; Guta A; de Prinse K; Chan Carusone S; Strike C
    Soc Sci Med; 2015 May; 133():77-84. PubMed ID: 25841098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implementation of a continuum of care for people living with HIV/AIDS in Hanoi (Vietnam)].
    de Loenzien M
    Sante; 2009; 19(3):141-8. PubMed ID: 20185390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and opportunities to integrating family members of injection drug users into harm reduction efforts within the Atlantic Canadian context.
    Jackson LA; Dykeman M; Gahagan J; Karabanow J; Parker J
    Int J Drug Policy; 2011 Sep; 22(5):385-92. PubMed ID: 21742479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illicit drug use while admitted to hospital: Patient and health care provider perspectives.
    Strike C; Robinson S; Guta A; Tan DH; O'Leary B; Cooper C; Upshur R; Chan Carusone S
    PLoS One; 2020; 15(3):e0229713. PubMed ID: 32134973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study.
    Limbu B
    Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
    Myers T; Cockerill R; Millson M; Rankin J; Worthington C
    AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a participatory needs assessment demonstrate an opportunity to involve people who use alcohol in drug user activism and harm reduction.
    Crabtree A; Latham N; Bird L; Buxton J
    Harm Reduct J; 2016 Dec; 13(1):37. PubMed ID: 27938376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.
    McNeil R; Kerr T; Pauly B; Wood E; Small W
    Addiction; 2016 Apr; 111(4):685-94. PubMed ID: 26498577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving from a project to programmatic response: scaling up harm reduction in Asia.
    Chatterjee A; Sharma M
    Int J Drug Policy; 2010 Mar; 21(2):134-6. PubMed ID: 20079618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vietnam moves forward with harm reduction: an assessment of progress.
    Reid G; Higgs P
    Glob Public Health; 2011; 6(2):168-80. PubMed ID: 20155544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.